Clinical Trial Update: SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing efficacy and safety of SHR-1209 for primary hypercholesterolemia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• SHR-1209

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED